News about Abbott Laboratories
It also has parallels to Valeant—and not in a good way.
But Alere says that none of the arguments made by Abbott give it grounds to abandon the merger.
But not the ones you're probably remembering.
University of Michigan experts could not confirm flaws alleged last week.